Y. Aujard
About
In The Last Decade
Y. Aujard
129 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 132
- Epidemiology 1.3k
- Public Health, Environmental and Occupational Health 911
- Microbiology 591
- Infectious Diseases 445
- Molecular Medicine 372
Countries citing papers authored by Y. Aujard
This map shows the geographic impact of Y. Aujard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Aujard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Aujard more than expected).
Fields of papers citing papers by Y. Aujard
This network shows the impact of papers produced by Y. Aujard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Aujard. The network helps show where Y. Aujard may publish in the future.
Co-authorship network of co-authors of Y. Aujard
This figure shows the co-authorship network connecting the top 25 collaborators of Y. Aujard. A scholar is included among the top collaborators of Y. Aujard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Aujard. Y. Aujard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 33 | |
| 3 | 31 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 12 | |
| 8 | 24 | |
| 9 | 3 | |
| 10 | 5 | |
| 11 | 21 | |
| 12 | Infections néonatales à Pseudomonas aeruginosa et atteintes neuroméningées. Intérêt de la ciprofloxacine | 3 |
| 13 | 68 | |
| 14 | 19 | |
| 15 | [Modalities of treatment local and general, medicamentous or not, controlling neonate suspected to be infected/contaminated by HSV1 or HSV2]. | 9 |
| 16 | Méningites bactériennes du nouveau-né : aspects diagnostiques et thérapeutiques | 1 |
| 17 | 24 | |
| 18 | 21 | |
| 19 | 31 | |
| 20 | Pharmacocinétique des antibiotiques chez le prématuré. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.